Segment 1: Few infected convicts in Missouri prisons are receiving newer hepatitis C drugs that are more effective, and more expensive.
According to an Emory University study, about 30 percent of individuals with hepatitis C infection in this country will pass through the U.S. correctional system in a given year. Few of them will receive the needed and effective treatment for the disease. Today, we learned why inmates are likely not receiving the antivirals that could save their lives.
- Alex Smith, KCUR health reporter
- Dr. Anne Spaulding, Emory University associate professor at the Rollins School of Public Health
Segment 2, beginning at 20:46: Provocative digital campaign draws attention to childhood trauma in Kansas City.
To become more active participants in their communities, underserved teens in the Youth Ambassadors education and employment programs are giving voice to their lived experiences. In the second half of the program, one participant explained how a new series of provocative short videos was inspired by his and other ambassadors' stories.
- Josie Hoskins, Paseo Academy of Fine Arts graduate
- Paige O'Connor, Youth Ambassadors executive director